Has my stock been accused of fraud?Join over 160k users who know.

Ticker Price Change($) Change(%) Shares Volume Prev Close Open Gain($) Gain(%)
Ticker Status Jurisdiction Filing Date CP Start CP End CP Loss Deadline
Ticker Case Name Status CP Start CP End Deadline Settlement Amt
Ticker Name Date Analyst Firm Up/Down Target ($) Rating Change Rating Current

News

Y-MAbs Therapeutics Says Preclinical GD2-SADA Data Will Be Presented At Society Of Nuclear Medicine & Molecular Imaging 2024 Annual Meeting

Author: Benzinga Newsdesk | June 07, 2024 07:09am

Posted In: YMAB